Financials data is unavailable for this security.
View more
Year on year MedPeer Inc had net income fall -23.97% from 812.39m to 617.68m despite a 72.04% increase in revenues from 8.45bn to 14.54bn. An increase in the cost of goods sold as a percentage of sales from 40.44% to 52.78% was a component in the falling net income despite rising revenues.
| Gross margin | 45.65% |
|---|---|
| Net profit margin | 4.38% |
| Operating margin | 6.04% |
| Return on assets | 4.71% |
|---|---|
| Return on equity | 7.74% |
| Return on investment | 5.66% |
More ▼
Cash flow in JPYView more
In 2023, cash reserves at MedPeer Inc fell by 745.59m. Cash Flow from Financing totalled 3.67bn or 25.21% of revenues. In addition the company generated 600.07m in cash from operations while cash used for investing totalled 5.01bn.
| Cash flow per share | 65.39 |
|---|---|
| Price/Cash flow per share | 9.10 |
| Book value per share | 386.56 |
|---|---|
| Tangible book value per share | 195.12 |
More ▼
Balance sheet in JPYView more
| Current ratio | 3.85 |
|---|---|
| Quick ratio | 3.83 |
| Total debt/total equity | 0.4043 |
|---|---|
| Total debt/total capital | 0.2879 |
More ▼
Growth rates in JPY
Year on year, growth in earnings per share excluding extraordinary items dropped -21.79%. Additionally, five year annualized earnings per share growth is in-line with the industry average relative to its peers.
| Div yield(5 year avg) | 0.09% |
|---|---|
| Div growth rate (5 year) | -- |
| Payout ratio (TTM) | 15.29% |
| EPS growth(5 years) | 19.96 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | 16.29 |
More ▼
